Table 2.
Mean differences in maternal cardiovascular markers among women with prior preterm birth with (+) and without (−) placental evidence of malperfusion, compared to women with term births, adjusted for pre-pregnancy features and interval from pregnancy to cardiovascular screening visit
Preterm, + Malperfusion (n=48) | Preterm, - Malperfusion (n=67) | |||
---|---|---|---|---|
difference | p* | difference | p* | |
Cholesterol (mg/dl) | 13.5 (6.1) | 0.035 | 8.0 (5.2) | 0.141 |
LDL-C (mg/dl) | 9.1 (5.4) | 0101 | 9.4 (4.6) | 0.052 |
Triglycerides (mg/dl) | 16.2 (9.2) | 0.092 | 10.7 (8.0) | 0.191 |
HDL-C (mg/dl) | 1.3 (2.1) | 0.548 | −0.3 (1.8) | 0.112 |
Apolipoprotein-B (mg/dl) | 8.0 (4.0) | 0.060 | 5.5 (3.5) | 0.129 |
Systolic BP (mmHg) | 4.0 (1.7) | 0.028 | 1.3 (1.5) | 0.386 |
Diastolic BP (mmHg) | 2.0 (1.3) | 0.146 | 0.9 (1.2) | 0.459 |
IMT (mm) | 0.014 (.01) | 0.231 | .012 (.01) | 0.214 |
Groups are compared to women with term births, adjusted for race, age at delivery, pre-pregnancy BMI, smoking during pregnancy and years between pregnancy and cardiovascular screening visit